Reuters logo
BRIEF-Bioblast Pharma reports Q2 loss per share $0.10
August 4, 2017 / 8:27 PM / 4 months ago

BRIEF-Bioblast Pharma reports Q2 loss per share $0.10

Aug 4 (Reuters) - Bioblast Pharma Ltd-

* Bioblast Pharma reports second quarter 2017 financial results

* Q2 loss per share $0.10

* Bioblast Pharma Ltd - ‍ Colin Foster and Ralf Rosskamp, MD, have submitted their resignations as members of board, effective August 31, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below